Alterations in frequency and function of thymus-derived FoxP3+ Tregs have been implicated in the pathogenesis of MS [14,15], whether CD52highCD4+ T cells are involved in MS pathology has not been investigated so far. This evidence concerns the gene FOXP3 and myeloid sarcoma.